MeetMe, Inc. (NASDAQ:MEET) represented a move of 8.76 percent or $-0.23 per share and closed its previous day trading session at $2.73. 939459 Shares were traded in the last trading session with an Average Volume of 1.08 Million Shares. The stock currently has a Market Capitalization of 197.57 Million.
The Meet Group, Inc. is a social media technology company. It offers information sharing, social interaction and mobile application development services. The company’s app consists of currently MeetMe (R), Skout(R), Tagged(R) and Hi5(R). The Meet Group Inc., formerly known as MeetMe Inc., is headquartered in New Hope, Pennsylvania.
The stock traded between $2.19 and $6.45 over 1-Year time period showing its price to sales ratio of 1.75. MeetMe, Inc. (NASDAQ:MEET) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $1.4 and 200-Day Simple Moving Average of $-27.87. Its Price to Free Cash Flow is 6.12 and Price to Book of 0.78.
Analyst’s recommended the stock as 2.5 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, MeetMe, Inc. (NASDAQ:MEET) reported its Actual EPS of $0.11/share. The analysts offering Earnings Estimates for the company were believing that MeetMe, Inc. could bring EPS of $0.1/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 10 Percent.
OncoSec Medical Incorporated (NASDAQ:ONCS)
In the last trading session, OncoSec Medical Incorporated (NASDAQ:ONCS) added its value by 3.72% closing at the price of $1.95. The stock currently has market capitalization of 69.21 Million, with average volume of 948.85 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently OncoSec Medical Incorporated (NASDAQ:ONCS) is showing beta of 3.22. This particular value of beta suggests that OncoSec Medical Incorporated (NASDAQ:ONCS) has historically moved 322% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for OncoSec Medical Incorporated (NASDAQ:ONCS) is at $-1.03.
The stock currently has RSI of 56.73. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
OncoSec Medical Incorporated is a biomedical company engaged in the designing, development and commercialization of therapeutic oncology products. It also develops novel OMS ElectroOncology therapies and OncoSec Medical System for the treatment of solid tumors. OncoSec Medical Incorporated is based in San Diego, California.
OncoSec Medical Incorporated (NASDAQ:ONCS) topped its 52-week high price of $2.95 on 11/13/17 and 52-Week Low Price of $0.88 on 08/21/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 9.96% and monthly volatility of 7.88% respectively.